tiprankstipranks
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market
Want to see HK:6855 full AI Analyst Report?

Compare Ascentage Pharma Group International (6855) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ascentage Pharma Group International
HK$50.90
HK$16.21B
-6.78
-5.65%
2 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$11.75
HK$20.82B
50.10
45.86%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$42.31B
-256.36
71.22%
3 Buy
0 Hold
0 Sell
Strong Buy
Everest Medicines Ltd.
HK$51.50
HK$11.94B
-30.06%
2 Buy
0 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$13.79
HK$31.04B
9.28
38.75%
3 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Henlius Biotech, Inc. Class H
HK$84.45
HK$42.47B
113.52%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6855
Ascentage Pharma Group International
43.78
-4.02
-8.41%
HK:9969
InnoCare Pharma Ltd.
13.93
4.29
44.50%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.58
10.80
73.07%
HK:1952
Everest Medicines Ltd.
33.78
-13.77
-28.96%
HK:2096
Simcere Pharmaceutical Group Limited
11.96
3.38
39.39%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
78.15
42.65
120.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts